JP2014015489A5 - - Google Patents

Download PDF

Info

Publication number
JP2014015489A5
JP2014015489A5 JP2013225889A JP2013225889A JP2014015489A5 JP 2014015489 A5 JP2014015489 A5 JP 2014015489A5 JP 2013225889 A JP2013225889 A JP 2013225889A JP 2013225889 A JP2013225889 A JP 2013225889A JP 2014015489 A5 JP2014015489 A5 JP 2014015489A5
Authority
JP
Japan
Prior art keywords
ylthio
dichlorobenzyl
thiazol
carboxymethyl
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013225889A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014015489A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2013225889A priority Critical patent/JP2014015489A/ja
Priority claimed from JP2013225889A external-priority patent/JP2014015489A/ja
Publication of JP2014015489A publication Critical patent/JP2014015489A/ja
Publication of JP2014015489A5 publication Critical patent/JP2014015489A5/ja
Pending legal-status Critical Current

Links

JP2013225889A 2006-07-11 2013-10-30 モルホリン化合物の塩 Pending JP2014015489A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2013225889A JP2014015489A (ja) 2006-07-11 2013-10-30 モルホリン化合物の塩

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2006190437 2006-07-11
JP2006190437 2006-07-11
JP2013225889A JP2014015489A (ja) 2006-07-11 2013-10-30 モルホリン化合物の塩

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2008524814A Division JP5501615B2 (ja) 2006-07-11 2007-07-11 モルホリン化合物の塩

Publications (2)

Publication Number Publication Date
JP2014015489A JP2014015489A (ja) 2014-01-30
JP2014015489A5 true JP2014015489A5 (OSRAM) 2014-03-20

Family

ID=38923247

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008524814A Expired - Fee Related JP5501615B2 (ja) 2006-07-11 2007-07-11 モルホリン化合物の塩
JP2013225889A Pending JP2014015489A (ja) 2006-07-11 2013-10-30 モルホリン化合物の塩

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2008524814A Expired - Fee Related JP5501615B2 (ja) 2006-07-11 2007-07-11 モルホリン化合物の塩

Country Status (6)

Country Link
US (1) US8030303B2 (OSRAM)
EP (1) EP2042499B1 (OSRAM)
JP (2) JP5501615B2 (OSRAM)
ES (1) ES2687756T3 (OSRAM)
TW (1) TWI399375B (OSRAM)
WO (1) WO2008007691A1 (OSRAM)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2042499B1 (en) * 2006-07-11 2018-06-27 Mitsubishi Tanabe Pharma Corporation Salt of a morpholine compound
JP6382816B2 (ja) * 2013-07-24 2018-08-29 田辺三菱製薬株式会社 眼科疾患治療剤
WO2020203822A1 (ja) * 2019-03-29 2020-10-08 千寿製薬株式会社 血管新生を伴う網膜疾患の治療又は予防のための併用医薬

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005097120A (ja) 2000-10-06 2005-04-14 Mochida Pharmaceut Co Ltd 4−ヒドロキシピペリジン誘導体の非潮解性塩
ATE388947T1 (de) * 2002-12-23 2008-03-15 Lundbeck & Co As H Escitalopramhydrobromid und ein verfahren zu dessen herstellung
WO2006028284A1 (ja) * 2004-09-08 2006-03-16 Mitsubishi Pharma Corporation モルホリン化合物
KR101137880B1 (ko) 2004-12-31 2012-04-20 엘지디스플레이 주식회사 쉬프트 레지스터 및 그 구동 방법
EP2042499B1 (en) * 2006-07-11 2018-06-27 Mitsubishi Tanabe Pharma Corporation Salt of a morpholine compound

Similar Documents

Publication Publication Date Title
JP2013237682A5 (OSRAM)
JP2015500331A5 (OSRAM)
JP2018024682A5 (OSRAM)
JP2017527578A5 (OSRAM)
HRP20210388T4 (hr) Kristalni polimorf slobodne baze od 2-hidroksi-6-((2-(1-izopropil-1h-pirazol-5-il)piridin-3-il)metoksi)benzaldehida
JP2011522816A5 (OSRAM)
HRP20211011T1 (hr) N-[4-fluor-5-[[(2s,4s)-2-metil-4-[(5-metil-1,2,4-oksadiazol-3-il)metoksi]-1-piperidil]metil]tiazol-2-il]acetamid kao inhibitor oga
JP2016041701A5 (OSRAM)
JP2015145426A5 (OSRAM)
NZ712180A (en) Pyridazinone compounds and methods for the treatment of cystic fibrosis
SI2956452T1 (en) Heterocyclic amides as kinase inhibitors
RU2599785C3 (ru) Кристаллические формы 5-хлор-n2-(2-изопропокси-5-метил-4-пиперидин-4-ил-фенил)-n4-[2-(пропан-2-сульфонил)-фенил]-пиримидин-2,4-диамина
JP2016503010A5 (OSRAM)
JP2014162794A5 (OSRAM)
NZ625087A (en) Combination formulation of two antiviral compounds
HRP20211834T1 (hr) Kristalni čvrsti oblici 6-karboksi-2-(3,5-diklorfenil)benzoksazola
JP2010132668A5 (OSRAM)
RU2019105794A (ru) Кристаллогидрат соединения (2s, 3r) -изопропил 2 - (((2- (1,5-диметил-6-оксо-1,6-дигидропиридин-3-ил) -1 - ((тетрагидро-2h-пиран) -4-ил) метил) -1h-бензо [d] имидазол-5-ил) метил) амино) -3-гидроксибутаноат эдисилат
JP2016510768A5 (OSRAM)
WO2013188283A8 (en) Topical ophthalmological pharmaceutical composition containing sunitinib
JP2016540749A5 (OSRAM)
JP2014015489A5 (OSRAM)
JP2015516425A5 (OSRAM)
JP2007532560A5 (OSRAM)
JP2016539985A5 (OSRAM)